### ICB_Wolf

- **Read Paper:** [PMID: 35623341](https://pubmed.ncbi.nlm.nih.gov/35623341/)
- **Objective:** The goal of the trial is to assess the activity of novel drugs, typically combined with weekly paclitaxel, in a priori defined biomarker subsets based on hormone receptor (HR), human epidermal growth factor receptor-2 (HER2) expression, and MammaPrint (MP) status.
- **Clinical Data:** [NIHMS1829047-supplement-3.xlsx](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721896/)
- **Processed Data:** [GSE196096](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE194040)
- **Cloud-Based Data:** [ISPY2 Data Results](https://www.ispytrials.org/results/data)


